KCT0008254尚未招募Unknown
Comprehensive study for the potential blood-based biomarkers for EGFR-mutant NSCLC patients treated with lazertinib
Kyung Hee University Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1) A person who has given written consent to participate in this study
- •2) Adult men and women over 19 years of age
- •3) Patients with histologically or cytologically confirmed non-small cell lung cancer
- •4) Patients scheduled to receive Lazertinib after T790M mutation was confirmed positive after treatment failure with 1st or 2nd generation EGFR-TKIs
- •5) Patients with ECOG PS of 0~2
排除标准
- •1) Patients who have received systemic steroid or immunosuppressant treatment within 2 weeks prior to Lazertinib administration
- •2) Patients who received antibiotic treatment within 2 weeks prior to Lazertinib administration
- •3) Patients currently being treated for connective tissue disease or inflammatory bowel disease
- •4) Patients confirmed as positive for ALK fusion
- •5) Patients with confirmed malignant tumors prior to participating in this study
- •However, registration is possible in the following cases, but registration is not possible if the patient is accompanied by a malignant tumor requiring current treatment.
- •- Cases confirmed as malignant tumors (including lung cancer) but in remission for more than 5 years after completion of treatment
- •-Efficiently treated non-melanoma skin cancer, cervical carcinoma in situ, mammary ductal carcinoma in situ, localized prostate cancer, and thyroid cancer treated for curative purposes can be registered.
研究者
相似试验
招募中
3 期
Investigating the effect of using the blood of a brain dead liver donor patient during liver transplantation on the liver recipient patientIVER TRANSPLANT.Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedureY83.0IRCT20211008052699N2Shiraz University of Medical Sciences124
招募中
不适用
Tissue and Blood-based Biomarker in Colorectal CancerColorectal cancerACTRN12621000976886The Walter and Eliza Hall Institute of Medical Research (WEHI)1,000
已完成
不适用
Prospective study to examine whether Blood N-terminal proBNP (N-terminal pro brain natriuretic peptide) can be used as an indicator of cardiac preload during massive fluid resuscitation in critically ill patients.JPRN-UMIN000004671Emergency Medicine60
已完成
不适用
A study to evaluate the response of whole blood stimulation with lipopolysaccharide or other inducers and its in vitro inhibition in healthy volunteers, and patients with a chronic inflammatory conditioatherosclerose100110821000381610003216rheumatoid arthritisNL-OMON38316Centre for Human Drug Research250
招募中
不适用
Analysis of genome and blood components for elucidation and treatment on mood disorderMood disorderJPRN-UMIN000006264Social medical corporation Koutokukai Sato Hospital10,000